Atrial Fibrillation and Cardiovascular Risk Assessment among COVID-19 Patients Using Different Scores

Area of Science:

• Cardiology
• Infectious Diseases
• Medical Informatics

Background:

• Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is associated with significant cardiovascular complications, including thromboembolism and arrhythmia.
• Atrial fibrillation (AF) is a common arrhythmia that can increase morbidity and mortality in patients with COVID-19.

Purpose of the Study:

• To investigate the utility of existing clinical scores in predicting atrial fibrillation (AF) and in-hospital mortality among patients infected with SARS-CoV-2.
• To understand the mechanisms linking SARS-CoV-2 infection to cardiovascular damage and AF.
• To compare the predictive performance of different scores for in-hospital mortality in COVID-19 patients.

Main Methods:

• Review and analysis of existing clinical scores used for AF identification and complication prediction.
• Discussion of the pathophysiological mechanisms of AF and cardiovascular damage in the context of SARS-CoV-2 infection.
• Comparative analysis of different scores for their efficacy in predicting in-hospital mortality in COVID-19 patients.

Main Results:

• Existing scores may offer potential for early prediction of AF and in-hospital mortality in SARS-CoV-2 infected individuals.
• Understanding the specific mechanisms of cardiovascular damage in COVID-19 is crucial for risk stratification.
• Further validation is needed to confirm the reliability of these scores in diverse COVID-19 patient populations.

Conclusions:

• Existing clinical scores show promise for predicting atrial fibrillation and in-hospital mortality in COVID-19 patients.
• Investigating these scores can aid in early risk stratification and management of cardiovascular complications.
• This research highlights the importance of monitoring cardiovascular health in patients with SARS-CoV-2 infection.